Today: 29 January 2026
Subscribe
Browse Category

NASDAQ:ADPT News 7 January 2026

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

New York, January 7, 2026, 12:25 (EST) — Regular session Shares of Adaptive Biotechnologies rose 6.5% to $17.15 on Wednesday, after trading between $16.24 and $17.33, giving the company a market value of about $2.0 billion. The stock has traded between $4.32 and $21.89 over the past 52 weeks. The move matters now because investors have been bidding up riskier…
7 January 2026
·····

Stock Market Today

  • Caterpillar Q4 CY2025 Revenue Beats Estimates with 18% Growth
    January 29, 2026, 10:30 AM EST. Caterpillar (NYSE:CAT) reported Q4 CY2025 revenue of $19.13 billion, beating analyst estimates of $17.75 billion by 7.8% and marking an 18% year-on-year increase. Adjusted earnings per share (EPS) came in at $5.16, 9.5% above the consensus forecast of $4.71. Despite strong revenue growth, operating margin fell to 13.9% from 18% last year, with free cash flow margin also declining to 11.8%. CEO Joe Creed highlighted record quarterly sales amid the company's centennial year. Caterpillar's five-year compounded annual growth rate stands at 10.1%, outperforming peers, though recent revenue plateaued amid industry headwinds. Analysts forecast 4.8% revenue growth for the next year, slightly below the industrial sector average. The results reflect Caterpillar's resilience in a challenging construction machinery market.
Go toTop